NO20013161L - Preparater av ileum-gallesyretransportinhibitorer og kolesterylesteroverföringsproteininhibitorer for kardiovaskul¶reindikasjoner - Google Patents
Preparater av ileum-gallesyretransportinhibitorer og kolesterylesteroverföringsproteininhibitorer for kardiovaskul¶reindikasjonerInfo
- Publication number
- NO20013161L NO20013161L NO20013161A NO20013161A NO20013161L NO 20013161 L NO20013161 L NO 20013161L NO 20013161 A NO20013161 A NO 20013161A NO 20013161 A NO20013161 A NO 20013161A NO 20013161 L NO20013161 L NO 20013161L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- bile acid
- transfer protein
- ileum
- preparations
- Prior art date
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 239000003613 bile acid Substances 0.000 title 1
- 239000003354 cholesterol ester transfer protein inhibitor Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 102000012336 Cholesterol Ester Transfer Proteins Human genes 0.000 abstract 2
- 108010061846 Cholesterol Ester Transfer Proteins Proteins 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 229940077672 Ileal bile acid transport inhibitor Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11395598P | 1998-12-23 | 1998-12-23 | |
US14304799P | 1999-07-07 | 1999-07-07 | |
PCT/US1999/027947 WO2000038726A1 (fr) | 1998-12-23 | 1999-12-17 | Combinaisons d'inhibiteurs de transport de l'acide biliaire ileal et d'inhibiteurs de la proteine de transfert de l'ester de cholesteryle utilisees dans le cadre de maladies cardio-vasculaires |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20013161D0 NO20013161D0 (no) | 2001-06-22 |
NO20013161L true NO20013161L (no) | 2001-08-17 |
Family
ID=26811682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013161A NO20013161L (no) | 1998-12-23 | 2001-06-22 | Preparater av ileum-gallesyretransportinhibitorer og kolesterylesteroverföringsproteininhibitorer for kardiovaskul¶reindikasjoner |
Country Status (23)
Country | Link |
---|---|
US (2) | US6458851B1 (fr) |
EP (2) | EP1140188B1 (fr) |
JP (1) | JP2002533412A (fr) |
KR (1) | KR20010108046A (fr) |
CN (1) | CN1342089A (fr) |
AT (1) | ATE241386T1 (fr) |
AU (1) | AU776620B2 (fr) |
BR (1) | BR9916486A (fr) |
CA (1) | CA2356422C (fr) |
CZ (1) | CZ20012340A3 (fr) |
DE (1) | DE69908414T2 (fr) |
DK (1) | DK1140188T3 (fr) |
EA (1) | EA005815B1 (fr) |
ES (1) | ES2200587T3 (fr) |
HK (2) | HK1041443A1 (fr) |
HU (1) | HUP0201972A3 (fr) |
IL (1) | IL143946A0 (fr) |
MX (1) | MXPA01006471A (fr) |
NO (1) | NO20013161L (fr) |
NZ (1) | NZ512536A (fr) |
PL (1) | PL348508A1 (fr) |
PT (1) | PT1140188E (fr) |
WO (1) | WO2000038726A1 (fr) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9916486A (pt) * | 1998-12-23 | 2002-02-05 | Searle Llc | Combinações de inibidores do transporte de ácidos biliares no ìleo e inibidores da proteìna de transferência do ester colesteril para indicações cardiovasculares |
CA2373073A1 (fr) * | 1999-05-07 | 2000-11-16 | Takeda Chemical Industries, Ltd. | Composes cycliques et leurs utilisations |
SE0000772D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | Chemical compounds |
EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
CN1582151A (zh) | 2001-09-08 | 2005-02-16 | 阿斯特拉曾尼卡有限公司 | 用于治疗高脂血症、具有回肠胆汁酸转运(ibat)抑制活性的苯并硫氮杂䓬和苯并硫杂二氮杂䓬衍生物 |
KR20050044352A (ko) * | 2001-11-09 | 2005-05-12 | 아테로제닉스, 인코포레이티드 | 심혈관 병리의 역전 및 예방 방법 |
EP1461069A2 (fr) * | 2001-12-29 | 2004-09-29 | Novo Nordisk A/S | Utilisation combinee d'un compose glp-1 et d'un autre medicament pour traiter la dyslipidemie |
GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
MXPA06003357A (es) | 2003-09-26 | 2006-06-08 | Japan Tobacco Inc | Metodo para inhibir la produccion de lipoproteina remanente. |
CA2624601C (fr) | 2004-10-06 | 2018-07-03 | The Brigham And Women's Hospital, Inc. | Pertinence de niveaux obtenus de marqueurs d'inflammation generalisee a la suite d'un traitement |
US20060257450A1 (en) * | 2005-03-21 | 2006-11-16 | Sreenivasu Mudumba | Drug delivery systems for treatment of diseases or conditions |
BRPI0608152A2 (pt) * | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
WO2007092620A2 (fr) | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Formulations stables et leurs procedes de preparation et d'utilisation |
CA2645488C (fr) | 2006-03-23 | 2014-09-02 | Macusight, Inc. | Formulations comprenant de la rapamycine et methodes d'utilisation de celle-ci destinees aux maladies ou aux pathologies liees a la permeabilite vasculaire |
WO2010062861A2 (fr) * | 2008-11-26 | 2010-06-03 | Satiogen Pharmaceuticals, Inc. | Inhibiteurs de recyclage de l'acide biliaire pour le traitement de l'obésité et du diabète |
EP2575821B1 (fr) | 2010-05-26 | 2015-08-12 | Satiogen Pharmaceuticals, Inc. | Inhibiteurs de recyclage d'acide biliaire et satiogènes pour traitement du diabète, de l'obésité et d'états inflammatoires gastro-intestinaux |
CA2815698C (fr) | 2010-11-08 | 2019-04-30 | Albireo Ab | Combinaison pharmaceutique comprenant un inhibiteur ibat et un liant d'acide biliaire |
SI2637668T1 (sl) | 2010-11-08 | 2016-11-30 | Albiero Ab | IBAT inhibitorji za zdravljenje jetrnih bolezni |
JP2012171911A (ja) | 2011-02-22 | 2012-09-10 | Kao Corp | Ppar活性化剤 |
CN107375932B (zh) | 2011-10-28 | 2021-12-21 | 夏尔人类遗传性治疗公司 | 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂 |
EA029581B1 (ru) | 2011-10-28 | 2018-04-30 | ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи | Применение ингибиторов рециркуляции желчных кислот для лечения холестатического заболевания печени или прурита |
EP2968262A1 (fr) | 2013-03-15 | 2016-01-20 | Lumena Pharmaceuticals, Inc. | Inhibiteurs de recyclage d'acide biliaire pour le traitement de l' sophage de barrett et du reflux gastro sophagien pathologique |
CA2907230A1 (fr) | 2013-03-15 | 2014-09-18 | Lumena Pharmaceuticals, Inc. | Inhibiteurs du recyclage de l'acide biliaire pour le traitement de l'angiocholite sclerosante primaire et de la maladie inflammatoire de l'intestin |
JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
US11266395B2 (en) | 2014-06-17 | 2022-03-08 | Ganihand, LLC | Devices and methods to provide hands free scleral depression during ophthalmic procedures |
KR20220082931A (ko) | 2014-06-25 | 2022-06-17 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 착색 방지 또는 착색 감소 방법 |
EP3012252A1 (fr) | 2014-10-24 | 2016-04-27 | Ferring BV | Formes crystallines d'Elobixibat |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
CN108601744B (zh) | 2016-02-09 | 2022-01-04 | 阿尔比里奥公司 | 口服考来烯胺制剂及其用途 |
JP6954927B2 (ja) | 2016-02-09 | 2021-10-27 | アルビレオ・アクチボラグ | 経口コレスチラミン製剤及びその使用 |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
CN111032019B (zh) | 2017-08-09 | 2022-07-05 | 阿尔比里奥公司 | 考来烯胺颗粒、口服考来烯胺制剂及其用途 |
CN110996915B (zh) | 2017-08-09 | 2023-10-03 | 阿尔比里奥公司 | 考来烯胺丸粒、口服考来烯胺制剂及其用途 |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
TW202015699A (zh) | 2018-06-05 | 2020-05-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途 |
WO2019245449A1 (fr) | 2018-06-20 | 2019-12-26 | Albireo Ab | Formulation pharmaceutique à base d'odévixibat |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
WO2020161216A1 (fr) | 2019-02-06 | 2020-08-13 | Albireo Ab | Composés de benzothiazépine et leur utilisation en tant que modulateurs de l'acide biliaire |
AU2020218908A1 (en) | 2019-02-06 | 2021-08-26 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
MX2021009622A (es) | 2019-02-12 | 2021-11-04 | Mirum Pharmaceuticals Inc | Metodos para tratar la colestasis. |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
AR120683A1 (es) | 2019-12-04 | 2022-03-09 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como ácido biliar |
CA3158276A1 (fr) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Composes de benzothia(di)azepine et leur utilisation en tant que modulateurs d'acide biliaire |
AR120676A1 (es) | 2019-12-04 | 2022-03-09 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como ácido biliar |
CR20220315A (es) | 2019-12-04 | 2022-10-26 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores del ácido biliar |
WO2021110887A1 (fr) | 2019-12-04 | 2021-06-10 | Albireo Ab | Composés de benzothiazépine et leur utilisation en tant que modulateurs de l'acide biliaire |
JP2023504644A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
CA3158181A1 (fr) | 2019-12-04 | 2021-06-10 | Albireo Ab | Composes de benzothia(di)azepine et leur utilisation en tant que modulateurs de l'acide biliaire |
WO2021110883A1 (fr) | 2019-12-04 | 2021-06-10 | Albireo Ab | Composés de benzothia(di)azépine et leur utilisation en tant que modulateurs de l'acide biliaire |
TW202134221A (zh) | 2019-12-04 | 2021-09-16 | 瑞典商艾爾比瑞歐公司 | 苯并噻二氮呯化合物及其作為膽酸調節劑之用途 |
JP2023537285A (ja) | 2020-08-03 | 2023-08-31 | アルビレオ・アクチボラグ | ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
KR20230106651A (ko) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트 |
EP4255565A1 (fr) | 2020-12-04 | 2023-10-11 | Albireo AB | Composés de benzothia(di)azepine et leur utilisation en tant que modulateurs de l'acide biliaire |
WO2023237728A1 (fr) | 2022-06-09 | 2023-12-14 | Albireo Ab | Traitement de l'hépatite |
Family Cites Families (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB860303A (en) | 1958-06-20 | 1961-02-01 | Ici Ltd | Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª |
US3253157A (en) | 1963-02-08 | 1966-05-24 | Robotron Corp | Timing circuit for actuating a load in accurate relationship to two inputs |
US3287370A (en) | 1965-06-08 | 1966-11-22 | Mcneilab Inc | Tetrahydrobenzothiepins |
US3389144A (en) | 1965-06-08 | 1968-06-18 | Mcneilab Inc | 5-pyridyl-2, 3, 4, 5-tetrahydrobenzothiepin-5-ols |
DE1593760A1 (de) | 1967-02-01 | 1972-06-08 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung neuer Benz-epinderivate |
US3444176A (en) | 1967-04-28 | 1969-05-13 | Mcneilab Inc | Certain 4-diloweralkylamino-lower alkyl - 5 - pyridyl (or phenyl)-2,3-dihydro - 1 - benzothiepins and derivatives thereof |
US3674836A (en) | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
US4058552A (en) | 1969-01-31 | 1977-11-15 | Orchimed Sa | Esters of p-carbonylphenoxy-isobutyric acids |
FR2077733B1 (fr) | 1970-02-10 | 1973-03-16 | Roussel Uclaf | |
US3694446A (en) | 1970-02-24 | 1972-09-26 | William J Houlihan | 5-(substituted-benzyl)-benzocycloheptenes and-1-benzthiepines |
US3692895A (en) | 1970-09-08 | 1972-09-19 | Norman A Nelson | Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria |
DE2230383C3 (de) | 1971-10-01 | 1981-12-03 | Boehringer Mannheim Gmbh, 6800 Mannheim | Phenoxyalkylcarbonsäurederivate und Verfahren zur Herstellung derselben |
US4002750A (en) | 1972-04-28 | 1977-01-11 | Carlo Erba S.P.A. | Pyrazine 4-oxide derivatives and process for their preparation |
US3948973A (en) | 1972-08-29 | 1976-04-06 | Sterling Drug Inc. | Halocyclopropyl substituted phenoxyalkanoic acids |
US3962261A (en) | 1974-02-04 | 1976-06-08 | Warner-Lambert Company | 2,3,4,5-tetra hydro-5-oxo-1-benzothiepi n-4-carboxamide 1,1-dioxides |
FR2260569B1 (fr) | 1974-02-08 | 1978-06-16 | Ugine Kuhlmann | |
JPS5612114B2 (fr) | 1974-06-07 | 1981-03-18 | ||
SE420725B (sv) | 1974-09-26 | 1981-10-26 | Ciba Geigy Ag | Sett att framstella 2,3-dihydro-1-benstiepin-4-karboxylsyraamider |
DE2739689C2 (de) | 1977-09-02 | 1986-10-16 | Euratom | Thermische Wärmepumpe |
US4251526A (en) | 1977-10-31 | 1981-02-17 | Mccall John M | 2-Benzothiepins and compositions and methods of use therefore |
US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
DE2928096A1 (de) | 1979-07-12 | 1981-02-05 | Basf Ag | Magnetischer aufzeichnungstraeger |
AU548996B2 (en) | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
AU548253B2 (en) | 1981-05-11 | 1985-12-05 | Pierre Fabre S.A. | Benzoxepine derivatives and sulphur and nitrogen analogues thereof |
US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
FI77669C (fi) | 1983-04-13 | 1989-04-10 | Ciba Geigy Ag | 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat. |
CA1247547A (fr) | 1983-06-22 | 1988-12-28 | Paul Hadvary | Derives de leucine |
EP0244364A3 (fr) | 1986-04-30 | 1992-04-01 | Sandoz Ag | Préparation de composés oléfiniques |
AU597671B2 (en) | 1986-06-20 | 1990-06-07 | Suntory Limited | 2-Phenylbenzoxepin derivative |
WO1989001477A1 (fr) | 1987-08-19 | 1989-02-23 | E.I. Du Pont De Nemours And Company | Procede de preparation de sels de sulfonylurees |
DE3835291A1 (de) | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
US5158943A (en) | 1988-11-21 | 1992-10-27 | Takeda Chemical Industries, Ltd. | Sulfur-containing heterocyclic compounds |
DE3901527A1 (de) | 1989-01-20 | 1990-07-26 | Hoechst Ag | Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate |
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
DE3930696A1 (de) | 1989-09-14 | 1991-03-28 | Hoechst Ag | Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel |
US5075293A (en) | 1989-10-10 | 1991-12-24 | The Dow Chemical Company | ((N-heterocyclyl)carbonyl)phosphoramidothioate ester insecticides |
US5153184A (en) | 1989-10-10 | 1992-10-06 | Dowelanco | ((N-heterocyclyl)carbonyl)phosphoramidothioate ester insecticides |
GB8926560D0 (en) | 1989-11-24 | 1990-01-17 | Zambeletti Spa L | Pharmaceuticals |
FR2661676A1 (fr) | 1990-05-02 | 1991-11-08 | Lipha | Derives d'amino benzocycloalcanes, procedes de preparation et medicaments les contenant. |
WO1992017467A1 (fr) | 1991-04-06 | 1992-10-15 | Dr Lo. Zambeletti S.P.A. | Composes azacycliques substitues, leur procede de preparation et leur utilisation a titre d'analgesiques |
EP0583346A1 (fr) | 1991-04-12 | 1994-02-23 | Schering Corporation | Amides bicycliques de l'acyle-coenzyme a: cholesterol acyltransferase |
AU1532492A (en) | 1991-04-18 | 1992-11-17 | Dr. Lo Zambeletti S.P.A. | Use of heterocyclic compounds for the treatment of inflammatory pain |
DE69127207T2 (de) | 1991-05-03 | 1998-01-22 | Raision Tehtaat Oy Ab | Substanz zur absenkung eines hohen cholesterolspiegels im serum und verfahren zu ihrer herstellung |
ES2111059T3 (es) | 1991-07-30 | 1998-03-01 | Ciba Geigy Ag | Derivados de hidroxilamina substituidos con heteroarilo como inhibidores de lipoxigenasa. |
US5334600A (en) | 1991-07-30 | 1994-08-02 | Ciba-Geigy Corporation | Isoquinolyl substituted hydroxylamine derivatives |
US5350761A (en) | 1991-07-30 | 1994-09-27 | Ciba-Geigy Corporation | Indolyl substituted hydroxylamine derivatives |
US5260316A (en) | 1991-07-30 | 1993-11-09 | Ciba-Geigy Corporation | Isoquinolyl substituted hydroxylamine derivatives |
US5356897A (en) | 1991-09-09 | 1994-10-18 | Fujisawa Pharmaceutical Co., Ltd. | 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines |
EP0534316A1 (fr) | 1991-09-21 | 1993-03-31 | Hoechst Aktiengesellschaft | Utilisation de dérivés alcoylés de polyéthylèneimine pour concentrer les acides biliaires |
US5519001A (en) | 1991-12-19 | 1996-05-21 | Southwest Foundation For Biomedical Research | CETP inhibitor polypeptide antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
EP0548793A3 (en) | 1991-12-20 | 1995-11-02 | Hoechst Ag | Ethylenic-unsaturated bile acid derivatives, process for their production and preliminary processes therefor |
ATE180968T1 (de) | 1991-12-20 | 1999-06-15 | Hoechst Ag | Polyaspartamidderivate als adsorptionsmittel für gallensäuren, mit gallensäuren beladene polyaspartamidderivate und verfahren zu deren herstellung sowie deren anwendung als arzneimittel |
ES2087422T3 (es) | 1991-12-20 | 1996-07-16 | Hoechst Ag | Polimeros y oligomeros de derivados de acidos biliares, procedimiento para su preparacion y su empleo como medicamento. |
US5244887A (en) | 1992-02-14 | 1993-09-14 | Straub Carl D | Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof |
GB9203347D0 (en) | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
ES2159283T3 (es) | 1992-02-29 | 2001-10-01 | Aventis Res & Tech Gmbh & Co | Complejos que contienen glicosil-fosfatidilinositol-proteinas y derivados de acido colanico, procedimiento para su preparacion y su utilizacion. |
ES2080549T3 (es) | 1992-03-28 | 1996-02-01 | Hoechst Ag | Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo. |
ATE307795T1 (de) | 1992-04-22 | 2005-11-15 | Ligand Pharm Inc | Verbindungen mit retinoid x rezeptorselektivität |
CA2093577C (fr) | 1992-05-07 | 2006-01-03 | Michael Klaus | Retinoides s-heterocyclique alkyl ou alkoxy substitues |
FR2698873B1 (fr) | 1992-12-07 | 1995-02-24 | Lipha | Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant. |
ZA941003B (en) | 1993-02-15 | 1995-08-14 | Wellcome Found | Hypolipidaemic compounds |
IL108634A0 (en) | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
JP3411036B2 (ja) | 1993-04-16 | 2003-05-26 | 塩野義製薬株式会社 | リグナン系化合物の製造方法 |
TW289020B (fr) | 1993-05-08 | 1996-10-21 | Hoechst Sktiengesellschaft | |
TW289021B (fr) | 1993-05-08 | 1996-10-21 | Hoechst Ag | |
EP0624593A3 (fr) | 1993-05-08 | 1995-06-07 | Hoechst Ag | Dérivés des acides biliaires, un procédé pour leur production et leur utilisation comme médicaments. |
US5703188A (en) | 1993-06-02 | 1997-12-30 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
IT1273751B (it) | 1994-02-11 | 1997-07-10 | Smithkline Beecham Farma | Derivati azaciclici |
ZA956647B (en) | 1994-08-10 | 1997-02-10 | Wellcome Found | Hypolipidaemic compounds. |
US5994391A (en) | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
WO1996008484A1 (fr) * | 1994-09-13 | 1996-03-21 | Monsanto Company | Nouvelles benzothiepines a activite inhibitrice du transport des acides biliaires en cas d'ileas et de l'absorption du taurocholate |
US5705524A (en) | 1994-11-04 | 1998-01-06 | Gilead Sciences, Inc. | Thiepane compounds |
US6034118A (en) | 1994-11-04 | 2000-03-07 | Gilead Sciences, Inc. | Thiepane compounds |
GB9423172D0 (en) | 1994-11-17 | 1995-01-04 | Wellcom Foundation The Limited | Hypolipidemic benzothiazepines |
WO1996040255A2 (fr) | 1995-06-07 | 1996-12-19 | G.D. Searle & Co. | Procede de traitement de la fibrose cardiaque par une combinaison therapeutique d'un antagoniste de l'angiotensine ii et d'un antagoniste de l'aldosterone epoxy-steroide |
JPH11510485A (ja) | 1995-07-21 | 1999-09-14 | ニィコメド・オーストリア・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 酵素のシクロオキシゲナーゼiiの阻害剤としてのベンゼンスルホンアミドの誘導体 |
GB2305665A (en) | 1995-09-26 | 1997-04-16 | Merck & Co Inc | Selective ß3 agonists for the treatment of diabetes aand obesity |
DE19610932A1 (de) | 1996-03-20 | 1997-09-25 | Bayer Ag | 2-Aryl-substituierte Pyridine |
EP0801060A1 (fr) | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Des agonistes bèta-3 adrénergiques hétérocycliques |
DE19627431A1 (de) * | 1996-07-08 | 1998-01-15 | Bayer Ag | Heterocyclisch kondensierte Pyridine |
HRP970330B1 (en) | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
DE19627430A1 (de) | 1996-07-08 | 1998-01-15 | Bayer Ag | Bicyclisch kondensierte Pyridine |
YU23499A (sh) * | 1996-11-27 | 2001-07-10 | Pfizer Inc. | Inhibitorski amidi apo-b-sekrecije/mtp-a |
ES2198613T3 (es) | 1997-03-14 | 2004-02-01 | Aventis Pharma Deutschland Gmbh | 1,4-benzotiazepina-1,1-dioxidos hipolipidemicos. |
JPH10287662A (ja) | 1997-04-08 | 1998-10-27 | Kitasato Inst:The | Fo−5637a物質及びb物質並びにそれらの製造法 |
US5929062A (en) | 1997-06-19 | 1999-07-27 | University Of Western Ontario | Oxysterol inhibition of dietary cholesterol uptake |
AU9297798A (en) * | 1997-09-16 | 1999-04-05 | G.D. Searle & Co. | Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity |
GB2329334A (en) | 1997-09-18 | 1999-03-24 | Reckitt & Colmann Prod Ltd | Cholesterol-lowering agents |
BR9916486A (pt) * | 1998-12-23 | 2002-02-05 | Searle Llc | Combinações de inibidores do transporte de ácidos biliares no ìleo e inibidores da proteìna de transferência do ester colesteril para indicações cardiovasculares |
DE19916108C1 (de) * | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
-
1999
- 1999-12-17 BR BR9916486-8A patent/BR9916486A/pt not_active Application Discontinuation
- 1999-12-17 WO PCT/US1999/027947 patent/WO2000038726A1/fr not_active Application Discontinuation
- 1999-12-17 HU HU0201972A patent/HUP0201972A3/hu unknown
- 1999-12-17 EP EP99965902A patent/EP1140188B1/fr not_active Expired - Lifetime
- 1999-12-17 KR KR1020017008085A patent/KR20010108046A/ko not_active Application Discontinuation
- 1999-12-17 NZ NZ512536A patent/NZ512536A/en unknown
- 1999-12-17 US US09/466,415 patent/US6458851B1/en not_active Expired - Fee Related
- 1999-12-17 PT PT99965902T patent/PT1140188E/pt unknown
- 1999-12-17 CZ CZ20012340A patent/CZ20012340A3/cs unknown
- 1999-12-17 IL IL14394699A patent/IL143946A0/xx unknown
- 1999-12-17 DK DK99965902T patent/DK1140188T3/da active
- 1999-12-17 CN CN99816268A patent/CN1342089A/zh active Pending
- 1999-12-17 MX MXPA01006471A patent/MXPA01006471A/es unknown
- 1999-12-17 EA EA200100705A patent/EA005815B1/ru not_active IP Right Cessation
- 1999-12-17 EP EP03011146A patent/EP1342475A1/fr not_active Withdrawn
- 1999-12-17 AT AT99965902T patent/ATE241386T1/de not_active IP Right Cessation
- 1999-12-17 PL PL99348508A patent/PL348508A1/xx not_active Application Discontinuation
- 1999-12-17 AU AU21578/00A patent/AU776620B2/en not_active Ceased
- 1999-12-17 JP JP2000590677A patent/JP2002533412A/ja active Pending
- 1999-12-17 DE DE69908414T patent/DE69908414T2/de not_active Expired - Fee Related
- 1999-12-17 CA CA002356422A patent/CA2356422C/fr not_active Expired - Fee Related
- 1999-12-17 ES ES99965902T patent/ES2200587T3/es not_active Expired - Lifetime
-
2001
- 2001-06-22 NO NO20013161A patent/NO20013161L/no not_active Application Discontinuation
-
2002
- 2002-04-10 HK HK02102732A patent/HK1041443A1/xx not_active IP Right Cessation
- 2002-07-23 US US10/200,599 patent/US20030203892A1/en not_active Abandoned
- 2002-08-22 HK HK02106168.1A patent/HK1044479A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000038726A1 (fr) | 2000-07-06 |
HK1041443A1 (en) | 2002-07-12 |
JP2002533412A (ja) | 2002-10-08 |
US20030203892A1 (en) | 2003-10-30 |
IL143946A0 (en) | 2002-04-21 |
ATE241386T1 (de) | 2003-06-15 |
PL348508A1 (en) | 2002-05-20 |
DE69908414D1 (de) | 2003-07-03 |
AU2157800A (en) | 2000-07-31 |
DE69908414T2 (de) | 2004-04-01 |
CA2356422C (fr) | 2008-09-16 |
BR9916486A (pt) | 2002-02-05 |
US6458851B1 (en) | 2002-10-01 |
EP1140188B1 (fr) | 2003-05-28 |
EA005815B1 (ru) | 2005-06-30 |
PT1140188E (pt) | 2003-10-31 |
NZ512536A (en) | 2003-11-28 |
CZ20012340A3 (cs) | 2001-11-14 |
HK1044479A1 (zh) | 2002-10-25 |
EA200100705A1 (ru) | 2002-02-28 |
MXPA01006471A (es) | 2004-03-10 |
KR20010108046A (ko) | 2001-12-07 |
EP1140188A1 (fr) | 2001-10-10 |
AU776620B2 (en) | 2004-09-16 |
NO20013161D0 (no) | 2001-06-22 |
CA2356422A1 (fr) | 2000-07-06 |
CN1342089A (zh) | 2002-03-27 |
EP1342475A1 (fr) | 2003-09-10 |
DK1140188T3 (da) | 2003-09-29 |
HUP0201972A2 (en) | 2002-10-28 |
HUP0201972A3 (en) | 2005-06-28 |
ES2200587T3 (es) | 2004-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20013161L (no) | Preparater av ileum-gallesyretransportinhibitorer og kolesterylesteroverföringsproteininhibitorer for kardiovaskul¶reindikasjoner | |
DK1140184T3 (da) | Kombinationer af cholesterylestertransferproteinhæmmere og nikotinsyrederivater til hjertekar indikationer | |
MXPA01006468A (es) | Combinaciones para indicaciones cardiovasculares. | |
MY121399A (en) | Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications | |
MXPA01006472A (es) | Combinaciones de inhibidores de transporte de acido biliar ileal y derivados de acido fibrico para indicaciones cardiovasculares. | |
AR022022A1 (es) | Combinaciones de inhibidores del transporte de acido ileo-biliar con agentes secuestrantes de acido biliar, para prescripciones cardiovasculares | |
NO20013158D0 (no) | Preparater av kolesterylesteroverföringsproteininhibitorer og fibrinsyrederivater for kardiovaskul¶re indikasjoner | |
ATE242008T1 (de) | Kombnationen von cholesteryl ester transfer protein inhibitoren und gallensäure sequestriermitteln für kardiovaskuläre indikationen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |